BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35738463)

  • 1. Development of an extended half-life GM-CSF fusion protein for Parkinson's disease.
    Yeapuri P; Olson KE; Lu Y; Abdelmoaty MM; Namminga KL; Markovic M; Machhi J; Mosley RL; Gendelman HE
    J Control Release; 2022 Aug; 348():951-965. PubMed ID: 35738463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-macrophage colony-stimulating factor mRNA and Neuroprotective Immunity in Parkinson's disease.
    Olson KE; Namminga KL; Lu Y; Thurston MJ; Schwab AD; de Picciotto S; Tse SW; Walker W; Iacovelli J; Small C; Wipke BT; Mosley RL; Huang E; Gendelman HE
    Biomaterials; 2021 May; 272():120786. PubMed ID: 33839625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Activities of Long-Acting Granulocyte-Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice.
    Olson KE; Namminga KL; Schwab AD; Thurston MJ; Lu Y; Woods A; Lei L; Shen W; Wang F; Joseph SB; Gendelman HE; Mosley RL
    Neurotherapeutics; 2020 Oct; 17(4):1861-1877. PubMed ID: 32638217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease.
    Schutt CR; Gendelman HE; Mosley RL
    Mol Neurodegener; 2018 May; 13(1):26. PubMed ID: 29783988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering superactive granulocyte macrophage colony-stimulating factor transferrin fusion proteins as orally-delivered candidate agents for treating neurodegenerative disease.
    Heinzelman P; Priebe MC
    Biotechnol Prog; 2015; 31(3):668-77. PubMed ID: 25737095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
    Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice.
    Kosloski LM; Kosmacek EA; Olson KE; Mosley RL; Gendelman HE
    J Neuroimmunol; 2013 Dec; 265(1-2):1-10. PubMed ID: 24210793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin fusion with granulocyte-macrophage colony-stimulating factor acts as an immunotherapy against chronic tuberculosis.
    Chuang YM; He L; Pinn ML; Tsai YC; Cheng MA; Farmer E; Karakousis PC; Hung CF
    Cell Mol Immunol; 2021 Oct; 18(10):2393-2401. PubMed ID: 32382128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells.
    Schanzer JM; Fichtner I; Baeuerle PA; Kufer P
    J Immunother; 2006; 29(5):477-88. PubMed ID: 16971804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cytokine granulocyte-macrophage colony-stimulating factor and chemokine macrophage inflammatory protein 2 mRNAs in macrophages by Legionella pneumophila or Salmonella typhimurium attachment requires different ligand-receptor systems.
    Yamamoto Y; Klein TW; Friedman H
    Infect Immun; 1996 Aug; 64(8):3062-8. PubMed ID: 8757834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased granulocyte-macrophage colony-stimulating factor mRNA instability in cord versus adult mononuclear cells is translation-dependent and associated with increased levels of A + U-rich element binding factor.
    Buzby JS; Lee SM; Van Winkle P; DeMaria CT; Brewer G; Cairo MS
    Blood; 1996 Oct; 88(8):2889-97. PubMed ID: 8874185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium ionophore upregulation of AUUUA-specific binding protein activity is contemporaneous with granulocyte macrophage colony-stimulating factor messenger RNA stabilization in AML14.3D10 cells.
    Ruth JH; Esnault S; Jarzembowski JA; Malter JS
    Am J Respir Cell Mol Biol; 1999 Nov; 21(5):621-8. PubMed ID: 10536121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease.
    Frank T; Klinker F; Falkenburger BH; Laage R; Lühder F; Göricke B; Schneider A; Neurath H; Desel H; Liebetanz D; Bähr M; Weishaupt JH
    Brain; 2012 Jun; 135(Pt 6):1914-25. PubMed ID: 22427327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine refacing effect reduces granulocyte macrophage colony-stimulating factor susceptibility to antibody neutralization.
    Heinzelman P; Carlson SJ; Cox GN
    Protein Eng Des Sel; 2015 Oct; 28(10):461-6. PubMed ID: 25855658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).
    Schäbitz WR; Krüger C; Pitzer C; Weber D; Laage R; Gassler N; Aronowski J; Mier W; Kirsch F; Dittgen T; Bach A; Sommer C; Schneider A
    J Cereb Blood Flow Metab; 2008 Jan; 28(1):29-43. PubMed ID: 17457367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor.
    Doherty DH; Rosendahl MS; Smith DJ; Hughes JM; Chlipala EA; Cox GN
    Bioconjug Chem; 2005; 16(5):1291-8. PubMed ID: 16173810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes.
    Borger P; Kauffman HF; Vijgen JL; Postma DS; Vellenga E
    Exp Hematol; 1996 Feb; 24(2):108-15. PubMed ID: 8641331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-4 inhibits interleukin-1 alpha-induced granulocyte-macrophage colony-stimulating factor gene expression in a murine B-lymphocyte cell line via downregulation of RNA precursor.
    Akahane K; Pluznik DH
    Blood; 1992 Jun; 79(12):3188-95. PubMed ID: 1596564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
    Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.